Citadel Securities Upgrades Express Scripts (ESRX) to Neutral; More Balanced Risk-Reward

July 20, 2011 7:27 AM EDT
Get Alerts ESRX Hot Sheet
Price: $92.33 --0%

Rating Summary:
    6 Buy, 20 Hold, 3 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Citadel Securities upgraded Express Scripts (NASDAQ: ESRX) from Reduce to Neutral. PT maintained at $53.

Citadel analyst says, "Medco (NYSE: MHS) and ESRX shares are down 11% and 4% YTD, respectively, as investors have come to more fully appreciate a more challenging organic operating environment in the midst of a generic conversion dynamic. Also becoming more accepted is our view that UNH will likely announce this year bringing in-house its commercialrisk PBM contract. However, we believe current valuations more accurately reflect the environment and while ‘11 results will likely be financially engineered to meet expectations, the generic conversion wave theme could once again lure market participants in 2H11."

For more ratings news on Express Scripts click here and for the rating history of Express Scripts click here.

Shares of Express Scripts closed at $51.85 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades